SCHEMBL25555474

SCHEMBL25555474

Bc1c(B)c(B)c(-c2ccc3c(c2)c2ccccc2n3-c2c(-c3c(B)c(B)c(B)c(B)c3B)cc([N+](=O)[O-])cc2-c2c(B)c(B)c(B)c(B)c2B)c(B)c1B

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.44
MEN1 O00255 7/20 0.41
KMT2A Q03164 7/20 0.41
LMNA P02545 2/20 0.41
POLB P06746 2/20 0.40
ATM Q13315 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.36
ALDH1A1 P00352 2/20 0.35
TSHR P16473 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
PDE4A P27815 1/20 0.33
PDE4B Q07343 1/20 0.33
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
F2R P25116 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
F2RL3 Q96RI0 1/20 0.32
MPI P34949 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25540485 0.81 MAPT (0.47) MAPTMEN1KMT2ALMNAPOLB
SCHEMBL25540636 0.79 MAPT (0.44) MAPTMEN1KMT2ALMNAPOLB
SCHEMBL25541409 0.78 KDM4E (0.32) ATML3MBTL1
SCHEMBL25556462 0.78 MEN1 (0.35) MAPTMEN1KMT2ALMNAPOLB
SCHEMBL25540557 0.77 MAPT (0.42) MAPTMEN1KMT2ALMNAPOLB
SCHEMBL25540515 0.76 MAPT (0.46) MAPTMEN1KMT2ALMNAPOLB
SCHEMBL25117677 0.75 KDM4E (0.36) MAPTMEN1KMT2ALMNAPOLB
SCHEMBL25649516 0.75 KDM4E (0.36) MAPTMEN1KMT2ALMNAPOLB
SCHEMBL29303883 0.75 KDM4E (0.36) MAPTMEN1KMT2ALMNAPOLB
SCHEMBL25649505 0.74 KDM4E (0.35) MAPTMEN1KMT2ALMNAATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159570-A1 LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE HETEROCYCLIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159570-A1 LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE HETEROCYCLIC COMPOUND CRY1, CYP1A1, NQO1 MAPT 3198/4885MEN1 241/4885KMT2A 1759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.